Gender Bias Dissected in eLife’s Peer Review

The journal undertook a self-assessment, finding men have more success than women with all-male review panels.

Written byViviane Callier
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Gender bias is present in a variety of scientific settings including faculty hiring, scientific publishing, grant funding, and more. Yet the review processes that generate these skewed outcomes largely happen behind closed doors, making them difficult to study.

A preprint posted on bioRxiv on August 29 takes a peek behind the curtain, providing insight into how bias creeps into the review process at the journal eLife—and suggests ways in which the review process could be improved to mitigate biases in the future.

The Scientist spoke with coauthors Jennifer Raymond, a neurobiologist at Stanford University and a reviewing editor at eLife, and Andrew Collings, executive editor at eLife, to learn more about their recent study.

TS: What motivated you to look for gender biases in peer review?

Jennifer Raymond: Recently, there was a meeting at AAAS on implicit bias and peer review. It was called in response to inquiries from some ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Viviane was a Churchill Scholar at the University of Cambridge, where she studied early tetrapods. Her PhD at Duke University focused on the role of oxygen in insect body size regulation. After a postdoctoral fellowship at Arizona State University, she became a science writer for federal agencies in the Washington, DC area. Now, she freelances from San Antonio, Texas.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies